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ABSTRACT 
 The neuroimmune system has become a major area of research into the pathology of 
alcoholism and stress. However, variation in neuro-cytokine responses to stress and withdrawal 
has impeded progress in defining the precise role the neuroimmune system plays. By measuring 
cytokine mRNA and protein levels along with obtaining behavioral data, the presented research 
further examines the function of the neuroimmune system with respect to ethanol exposure. 
Results broaden the body of literature in which the neuroimmune system has been shown to be 
altered by stress and withdrawal, importantly in adolescent animals. The increasing variety of 
methods and rat strains shown to have neuroimmune activation elicited by ethanol may point to a 
phenomenon that is more translationally applicable and clinically relevant. 
 
INTRODUCTION 
 The health effects of alcohol abuse and alcoholism have been well documented. Alcohol 
abuse disorder as defined by the DSM-IV has an estimated 5% prevalence and causes 79,000 
deaths annually in the United States (Grant et al. 2004, Bouchery et al. 2011). Additionally, 75% 
of chronic alcoholics show significant brain damage at autopsy (Vetreno et al. 2011). Disorders 
related to excessive alcohol use impose staggering socio-economic costs on the United States. 
The estimated national cost of alcohol abuse combining mortality, disease and injury, property 
damage, crime and lost productivity was $223.5 billion in 2006 (Bouchery et al. 2011). These 
statistics place alcohol abuse disorder as one of the most harmful and expensive preventable 
health disorders in the country. 
 Despite the severity of the issue, treatment options for alcoholics are limited and relapse 
rates for high-risk drinkers remain as high as 50% over a three year period (Dawson et al. 2007). 
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A major reason for the deficit in clinical treatment options is the incomplete understanding of the 
mechanisms through which ethanol exerts its pathologic effects on the brain. A mounting body 
of research implicates the neuroimmune system as an important player in all behavioral stages of 
addiction (intoxication, withdrawal, craving) as well as the neurotoxic effects of ethanol (Coller 
et al. 2012, Crews et al. 2011, He et al. 2008, Knapp et al. 2011). More specifically, this response 
is at least in part the pro-inflammatory action of glial cells in the CNS which may be activated by 
ethanol via the gut-brain axis or in local brain tissue (Mayfield et al. 2013). Activation of 
microglial toll-like receptor (TLR) by lipopolysaccharide or endogenous signals such as high-
mobility group box 1 (HMGB1), have been shown to be necessary for this glial pro-
inflammatory response (Fernandez-Lizarbe et al. 2009, Crews et al. 2012, Breese et al. 2013). 
This TLR signaling cascade culminates in the production of the transcription factor nuclear 
factor kappa-light-chain-enhancer of activated B cells (NF-κB), which induces production of 
pro-inflammatory cytokines such as interleukin-1 beta (IL-1β), tumor necrosis factor alpha 
(TNFα), monocyte chemotactic protein-1 (MCP-1), etc. (Zou et al. 2010). These cytokines have 
been shown to contribute to neuroinflammatory and behavioral effects in models of alcohol use 
disorder (Knapp et al. 2011). Some data have shown that cycled ethanol exposure may engender 
a more robust withdrawal than constant ethanol (Breese et al. 2005, 2011, Overstreet et al. 2002). 
Also, stress is known to be an important factor in alcoholic relapse by inducing anxiety-like 
behavior. Stress influences some of the same pro-inflammatory CNS effects as withdrawal, 
possibly via a corticotrophin releasing factor-dependent pathway (Breese et al. 2005, 2011, Sinha 
et al. 2007, Knapp et al. 2011). 
This paper addresses experiments in which the hypothesis tested was that the pro-
inflammatory signaling pathway in the CNS mediates the behavioral responses of rats to chronic 
Kendle 3 
 
cycled ethanol use and withdrawal combined with stress. Fischer rats were chosen because they 
exhibit a pronounced cytokine response to stress (Porterfield et al. 2011). Different brain regions 
were examined for cytokines in regard to their varying levels of involvement in stress and 
withdrawal (Porterfield et al. 2011, Johnson et al. 2005, O’Connor et al. 2003). Adolescent mice 
were examined due to the importance of this stage in the development of alcoholism and data 
reporting differences between adolescent and adult neuroimmune response (Kane et al. 2013). 
 
METHODS 
Animals 
 Young adult male Fischer 344 rats obtained from Harlan Sprague Dawley (Dublin, VA) 
were 42 days of age and weighed 90-100g upon arrival. Adolescent male Fischer 344 rats 
obtained from Harlan Sprague Dawley (Dublin, VA) were 23 days of age and weighed 30g upon 
arrival. All rats were then group housed and fed RMH3000 rat chow (TestDiets, Richmond, IN) 
for 2 to 3 days to acclimate them to the new environment (temperatures 70 to 72°F; humidity 40 
to 60%; and a 12-h light/12-h dark cycle). Animals were then singly housed for the 1-2 days 
immediately prior to study initiation. 
Diets 
 Ethanol-containing or control liquid diets were employed as previously described (e.g., 
Knapp et al. 2007). Briefly,  rats were exposed to either control liquid diet (CD) or a 4.5% 
ethanol liquid diet (ED), cycled 5 days on 2 days off for 3 cycles. ED rats were given 2.5% 
ethanol for the first day of treatment to adapt before shifting to 4.5%. The diets were nutritionally 
complete and calorically balanced with appropriate concentrations of dextrose versus ethanol. 
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Ethanol withdrawal was initiated by switching rats from ED to CD on the morning of the 
behavioral test. 
Stress Protocol 
 Restraint stress was applied by confining rats for 60 minutes in conical decapicones 
(Braintree Scientific, Braintree, MA) with rubber bands around the base of the rat’s tail to secure 
the animal in place. This stress was chosen because it has previously been shown to alter 
ethanol- and withdrawal- induced behaviors (Breese et al. 2005, Knapp et al. 2007). After stress, 
rats were sacrificed by decapitation and tissues collected either immediately or two hours 
following the end of stress, as noted for each group. 
Behavioral Tests 
 A social interaction test was utilized to quantify anxiety-like behavior during withdrawal. 
Rats were placed in an open field (60x60 cm, with 16 10x10 cm squares marked on the floor) 5-6 
hours after removal of ethanol. Rat pairs matched by weight and treatment when possible were 
placed in the arena, and time spent in social interaction was recorded during a 5-minute session, 
with lower scores taken as anxiety-like behavior (File et al. 1978, Breese et al. 2005). Locomotor 
activity (measured as count of line crosses) was recorded during the same sessions as a control 
for sedative or stimulant effects. 
Tissue Collection 
 Brains were collected following rapid decapitation, extraction and freezing in isopentane 
at -25 °C. Blood samples were collected following rapid decapitation, heparinized, kept on ice, 
centrifuged at 2600g for 10 min and the plasma supernatant collected and stored at -80 °C until 
assayed. 
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PCR 
 Total RNA was extracted from homogenized microdissected brain regions using Trizol. 
RNA was converted to cDNA by RT-PCR as described elsewhere. SYBR green PCR master mix 
(Applied Biosystems, Foster City, CA) was used for real time analysis. The cycle time values 
were normalized with β-actin to ascertain relative differences in mRNA expression between 
groups. Calculated values were expressed as relative change from controls, which were set as 
100%. Relevant primer sequences are listed in Table A1 of the appendix. 
ELISA 
 Brain region samples for ELISA were homogenized in Iscove’s Modified Dulbecco’s 
Medium (Invitrogen) with a complete protease inhibitor cocktail (Roche Diagnostics, 
Indianapolis, IN). Homogenized samples were centrifuged 10 minutes at 12,000g and 4°C. 
Supernatants were collected and stored at -80°C. ELISA kits for IL-1β and TNFα were 
purchased from R&D Systems (Minneapolis, MN) with standard curves diluted down three times 
further in 1:1 dilutions; for HMGB1 from IBL-International (Hamburg, Germany); and for MCP-
1 from BD Biosciences (Franklin Lakes, NJ). Other ELISA procedures were performed 
according to manufacturers’ directions. Cytokine levels were corrected by protein concentration 
using Pierce BCA Protein assay (Thermo Scientific, Rockford, IL). 
Statistics 
 Analysis of regional brain mRNA and protein expression across treatment groups was 
done by analysis of variance (ANOVA). Comparison of two groups after ANOVA used Fischer 
PLSD. When only two groups were present, t-tests were used. p-Values < 0.05 were considered 
statistically significant. Asterisks (*) indicate a statistically significant difference from controls 
in graphs. 
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RESULTS 
Fischer Young Adults: Cytokines Immediately and 2h Following Stress 
 The relationship between stress and cytokines was investigated. Cortical mRNA levels of 
various cytokines in young adult Fischer rats were determined after 1 hour restraint stress with 
immediate and 2 hour sac as described. MCP-1 showed a moderate but not significant decrease 
immediately with a return to control after 2 hours, TNFα showed a large decrease immediately 
and partially rebounded levels after 2 hours, and IL-1β showed no significant changes at either 
time (Tables 1 and 2, Fig. 1). While the MCP-1 levels showed no significant change, the pattern 
exhibited was similar to the significant change seen for TNFα. 
Table 1. Cortical MCP-1 mRNA following Restraint Stress (% Control) 
 Count Mean Std. Err. 
1h Restraint 2h Sac 5 103.7 13.0 
1h Restraint Immediate Sac 5 78.3 5.32 
Control 6 100.0 6.70 
 
Table 2. Cortical IL-1β mRNA following Restraint Stress (% Control) 
 Count Mean Std. Err. 
1h Restraint 2h Sac 5 112.9 9.49 
1h Restraint Immediate Sac 5 96.6 8.18 
Control 6 100.0 5.35 
 
 
Fig. 1. Cortical TNFα mRNA expression following restraint stress. A significant decrease immediately was followed 
by a partial return to control after 2h (ANOVA test p<0.05). Error bars ± 1 standard error. 
     * 
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 Expression of IL-1β and TNFα protein were also investigated in the plasma, cortex, and 
hypothalamus of the same animals. In the plasma, IL-1β exhibited a significant increase at both 
sac times following restraint stress (Fig. 2a). In the cortex, IL-1β was significantly lowered only 
at 2 hours following restraint stress (Fig. 2b). In the hypothalamus, IL-1β was significantly 
higher at both sac times following restraint stress (Fig. 3c). TNFα showed no significant changes 
(Tables 3, 4 and 5).  
 
Table 3. Plasma TNFα Protein following Restraint Stress (pg/mL) 
 Count Mean Std. Err. 
1h Restraint 2h Sac 6 2.99 0.49 
1h Restraint Immediate Sac 7 2.77 0.98 
Control 6 1.24 0.70 
 
Table 4. Cortical TNFα Protein following Restraint Stress (pg/mg) 
 Count Mean Std. Err. 
1h Restraint 2h Sac 6 0.39 0.026 
1h Restraint Immediate Sac 7 0.39 0.029 
Control 6 0.37 0.039 
 
 
 
   *  
  *  
*  
  *  
  *  
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Table 5. Hypothalamic TNFα Protein following Restraint Stress (pg/mg) 
 Count Mean Std. Err. 
1h Restraint 2h Sac 5 0.019 0.049 
1h Restraint Immediate Sac 5 0.101 0.042 
Control 6 0.076 0.026 
 
Fischer Adolescents: Cycled Ethanol, Withdrawal and Stress 
 Further data relating to the combination of withdrawal and stress was collected. Cortical 
mRNA levels of various cytokines in adolescent Fischer rats were determined after the 4.5% 
cycled ethanol treatment followed by 24 hr. withdrawal (WD), 1 hour restraint stress and 2 hour 
delayed sac as described. TNFα was elevated with cycled ethanol and lowered with ethanol and 
stress, IL-1β was elevated only with cycled ethanol alone, and MCP-1 and HMGB1 showed no 
change (Figure 3, Tables 6 and 7). No rats were stressed without being given cycled ethanol. 
 
Figure 3:Cortical Cytokine mRNA with cycled EtOH, WD and restraint stress. a) TNFα was significantly raised 
with EtOH alone and significantly lowered with EtOH + stress. b) IL-1β was significantly raised with EtOH alone, 
and returned to control with EtOH + stress. Error bars ± 1 standard error. 
Table 6. Cortical MCP-1 mRNA following Cycled Ethanol, WD and Restraint Stress (% 
control) 
 Count Mean Std. Err. 
4.5% Cycled EtOH, No Stress 5 118.3 2.65 
4.5% Cycled EtOH, Stress 6 101.1 9.42 
Control 5 100.0 8.24 
 
  *  
 *     *  
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Table 7. Cortical HMBG1 mRNA following Cycled Ethanol, WD and Restraint Stress (% 
control) 
 Count Mean Std. Err. 
4.5% Cycled EtOH, No Stress 5 118.3 3.00 
4.5% Cycled EtOH, Stress 6 104.7 6.82 
Control 5 100.0 8.51 
 
 Locomotor and social interaction test scores were collected 5-6 hours into withdrawal (1 
day prior to the stress manipulation). No significant difference was observed in locomotor scores 
between the cycled ethanol group and the control group (Table 8). Social interaction showed a 
significant reduction in interaction time in both the ethanol group and the ethanol with stress 
group (Figure 4). 
Table 8. Locomotor scores taken before stress protocol. 
 Count Mean Std. Err. 
4.5% Cycled EtOH 13 141.5 18.8 
Control 6 133.8 15.3 
 
 
Figure 4: Social interaction scores. Time spent in social interaction was significantly lowered for both cycled EtOH 
and cycled EtOH + restraint stress groups. Error bars ± 1 standard error. 
 
 
 
 
 *  
    *  
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DISCUSSION 
 The results of these experiments add to the growing body of literature pertaining to the 
interface between stress and withdrawal in chronic ethanol use. The cytokine data elucidates 
certain nuances in neuroimmune function, such as the stress/withdrawal challenge used in an 
adolescent rat. These results clearly demonstrate significant anxiety-like behavior paired with 
neuroimmune change with withdrawal in adolescents. This combination of age and short 
duration of drinking may be of great interest in the prevention of alcoholism. In addition, the 
cytokine data for young adult rats provide additional knowledge about the role of  stress in 
Fischer rats over time, though more studies must be done for a clearer picture. 
The young adult stress time course study cortical mRNA data demonstrated mixed 
results. IL-1β fell immediately then rebounded towards control at 2h, MCP-1 showed a similar 
but not significant pattern and TNFα showed no change. Though these cytokines have previously 
been shown to be raised in stress, these results are in agreement with much of the literature given 
the mild stressor used. It has been reported that restraint stress does not alter cortical cytokine 
mRNA, and tailshock stress has been shown to lower cortical IL-1β mRNA immediately 
followed by a return to control levels (O’Connor et al. 2003). However,  a comparison of 
Sprague-Dawley rat data showing no effect on cortical cytokines with Fischer data has brought 
to light potential  differences in neuroimmune response across strains (Porterfield et al. 2011). 
While mild stressors clearly have less neuroimmune effect than their counterparts, they may 
more closely parallel the stress paradigm encountered by some alcoholics and thus may be more 
broadly relevant to alcoholism. The next logical step was to investigate different brain regions 
and protein levels, the ultimate effectors of function on a cellular level. IL-1β and TNFα protein 
levels were measured in cortex, hypothalamus (a brain region implicated in withdrawal-induced 
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anxiety-like behavior), and plasma. IL-1β was raised at both sac times in plasma, lowered at the 
2h sac in cortex, and importantly raised at both sac times in hypothalamus; TNFα showed no 
significant change. IL-1β has been shown repeatedly to be raised in plasma following stressors 
(Johnson et al. 2005). The reason for the lack of change in TNFα may be regulation by other 
cytokines, as it has previously been reported to not be raised unless IL-6 is blocked (Nukin et al. 
1998). Data on IL-6 levels in a similar stress and animal model, or perhaps the same procedure 
done with IL-6 inhibited, would be needed to ascertain the validity of this action in this model. 
IL-1β protein has been shown to be lowered in cortex and raised in hypothalamus, though only 
with acute stressors in Sprague-Dawley rats (O’Connor et al. 2003, Johnson et al. 2005, 
Porterfield et al. 2011). The use of different rat strains and different stressors in these studies is 
important as it indicates a response that is relevant to a broad variety of stimuli. 
 The second study combined restraint stress with a cycled ethanol withdrawal challenge in 
adolescent rats, an important age group in the development of alcoholism. Stress coupled with 
chronic cycled EtOH was expected to yield the greatest cytokine and behavioral response due to 
the fact that both have been shown to cause similar effects on these measures. However, for both 
IL-1β and TNFα mRNA, levels were significantly raised only with withdrawal alone. In fact, 
TNFα mRNA was lowered in the withdrawal + stress group. The increase in cytokines following 
withdrawal alone agrees with previous studies (Breese et al. 2013). These findings mean that the 
same neuroimmune mechanisms may underlie both adolescent and adult rat phenotypes of 
withdrawal and drinking behavior, though the studies used different rat strains. The decrease in 
TNFα with withdrawal and stress is not quite as straightforward. It is possible that the data 
collected is not indicative of an actual drop in TNFα levels. This would be possible in the case of 
a downstream negative feedback loop in which a huge initial and effective increase in TNFα 
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protein activity causes changes that eventually lead to a downregulation of TNFα mRNA by the 
time data was obtained. Further studies of TNFα protein or mRNA turnover rate must be 
performed in order to better understand this result. For the behavioral test, locomotor scores 
showed no significant difference, meaning that differential locomotor scores did not confound 
anxiety-like behavior data. Social interaction scores showed significant anxiety-like behavior in 
the ethanol groups experiencing withdrawal, as seen in literature (Knapp et al. 2011, Breese et al. 
2011, Overstreet et al. 2002). Because this study into adolescent Fischer rats was preliminary, 
there was no control group for stress without ethanol, thus further interpretations of the stress-
alone variable are not presented here.  
 Neuroimmune function continues to be a promising field in drug abuse and other 
neuropsychiatric conditions. Pharmacologically, many drugs affecting the system have shown 
promise by affecting drinking behavior and lending hope for  better treatments for alcoholism 
(Coller et al. 2012). The data presented help to clarify the potential cytokine-based mechanisms 
of this system by further probing the effects of minor stressors, strain/genetic makeup, and age. 
Further studies will seek to determine if neuroimmune activation is necessary or sufficient to 
change anxiety-like behavior during withdrawal by directly manipulating cytokines and TLR 
signaling. 
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APPENDICES 
Table A1. Relevant Primer Sequences 
 
